1. Home
  2. GLPG vs BDJ Comparison

GLPG vs BDJ Comparison

Compare GLPG & BDJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLPG
  • BDJ
  • Stock Information
  • Founded
  • GLPG 1999
  • BDJ 2005
  • Country
  • GLPG Belgium
  • BDJ United States
  • Employees
  • GLPG N/A
  • BDJ N/A
  • Industry
  • GLPG Biotechnology: Pharmaceutical Preparations
  • BDJ Finance Companies
  • Sector
  • GLPG Health Care
  • BDJ Finance
  • Exchange
  • GLPG Nasdaq
  • BDJ Nasdaq
  • Market Cap
  • GLPG 1.8B
  • BDJ 1.5B
  • IPO Year
  • GLPG 2005
  • BDJ N/A
  • Fundamental
  • Price
  • GLPG $27.87
  • BDJ $8.77
  • Analyst Decision
  • GLPG Sell
  • BDJ
  • Analyst Count
  • GLPG 4
  • BDJ 0
  • Target Price
  • GLPG $25.33
  • BDJ N/A
  • AVG Volume (30 Days)
  • GLPG 259.2K
  • BDJ 561.6K
  • Earning Date
  • GLPG 07-23-2025
  • BDJ 01-01-0001
  • Dividend Yield
  • GLPG N/A
  • BDJ 8.85%
  • EPS Growth
  • GLPG N/A
  • BDJ N/A
  • EPS
  • GLPG N/A
  • BDJ N/A
  • Revenue
  • GLPG $311,493,731.00
  • BDJ N/A
  • Revenue This Year
  • GLPG $0.78
  • BDJ N/A
  • Revenue Next Year
  • GLPG N/A
  • BDJ N/A
  • P/E Ratio
  • GLPG N/A
  • BDJ N/A
  • Revenue Growth
  • GLPG 18.32
  • BDJ N/A
  • 52 Week Low
  • GLPG $22.36
  • BDJ $6.91
  • 52 Week High
  • GLPG $31.23
  • BDJ $8.66
  • Technical
  • Relative Strength Index (RSI)
  • GLPG 51.86
  • BDJ 62.13
  • Support Level
  • GLPG $26.62
  • BDJ $8.51
  • Resistance Level
  • GLPG $29.28
  • BDJ $8.63
  • Average True Range (ATR)
  • GLPG 0.58
  • BDJ 0.06
  • MACD
  • GLPG -0.16
  • BDJ 0.01
  • Stochastic Oscillator
  • GLPG 54.51
  • BDJ 93.79

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

About BDJ Blackrock Enhanced Equity Dividend Trust

BlackRock Enhanced Equity Dividend Trust is a United States closed-end management investment company. Its investment objective is to seek current income and current gains, with a secondary objective of long-term capital appreciation.

Share on Social Networks: